[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 48, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pauline  Dufresne", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 16.56, "open": 16.76, "dayLow": 16.76, "dayHigh": 18.3893, "regularMarketPreviousClose": 16.56, "regularMarketOpen": 16.76, "regularMarketDayLow": 16.76, "regularMarketDayHigh": 18.3893, "payoutRatio": 0.0, "trailingPE": 3.3364313, "forwardPE": -6.117011, "volume": 435310, "regularMarketVolume": 435310, "averageVolume": 700718, "averageVolume10days": 421050, "averageDailyVolume10Day": 421050, "bid": 12.96, "ask": 22.87, "bidSize": 2, "askSize": 2, "marketCap": 983336064, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 19.71, "allTimeHigh": 28.09, "allTimeLow": 7.8, "fiftyDayAverage": 16.8494, "twoHundredDayAverage": 13.484, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 695144000, "profitMargins": 0.0, "floatShares": 24210883, "sharesOutstanding": 54781950, "sharesShort": 8018780, "sharesShortPriorMonth": 7218989, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1464, "heldPercentInsiders": 0.12172, "heldPercentInstitutions": 0.92077005, "shortRatio": 11.36, "shortPercentOfFloat": 0.22850001, "impliedSharesOutstanding": 54781950, "bookValue": 7.375, "priceToBook": 2.4338984, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -121521000, "trailingEps": 5.38, "forwardEps": -2.93444, "enterpriseToEbitda": -4.929, "52WeekChange": 0.27482677, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 17.95, "targetHighPrice": 48.0, "targetLowPrice": 11.0, "targetMeanPrice": 30.44444, "targetMedianPrice": 30.0, "recommendationMean": 1.54545, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 290167008, "totalCashPerShare": 5.297, "ebitda": -141042000, "totalDebt": 1975000, "quickRatio": 13.799, "currentRatio": 14.142, "debtToEquity": 0.49, "returnOnAssets": -0.18591, "returnOnEquity": -0.26639998, "freeCashflow": -75155376, "operatingCashflow": -112980000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "regularMarketChangePercent": 8.39373, "regularMarketPrice": 17.95, "corporateActions": [], "postMarketTime": 1768005042, "regularMarketTime": 1767992401, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "marketState": "CLOSED", "postMarketChangePercent": 1.8941512, "postMarketPrice": 18.29, "postMarketChange": 0.34000015, "regularMarketChange": 1.39, "regularMarketDayRange": "16.76 - 18.3893", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 700718, "fiftyTwoWeekLowChange": 10.150001, "fiftyTwoWeekLowChangePercent": 1.301282, "fiftyTwoWeekRange": "7.8 - 19.71", "fiftyTwoWeekHighChange": -1.7599983, "fiftyTwoWeekHighChangePercent": -0.089294694, "fiftyTwoWeekChangePercent": 27.482677, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 5.38, "epsForward": -2.93444, "epsCurrentYear": -2.48111, "priceEpsCurrentYear": -7.2346654, "fiftyDayAverageChange": 1.1006012, "fiftyDayAverageChangePercent": 0.0653199, "twoHundredDayAverageChange": 4.4660006, "twoHundredDayAverageChangePercent": 0.3312074, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.5 - Buy", "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]